Faron Pharmaceuticals reports inconsistent Traumakine biomarker results
Top-line trial data were previously reported on 8 May 2018 and an update was provided on 11 May 2018. The biomarker data confirms that Traumakine treatment did not
AscellaHealth has acquired CHAPPER healthcare, a specialty pharmaceutical wholesaler, distributor and services provider, for undisclosed amount.
The Boston-based clinical-stage biotechnology company had been conducting the mid-stage trials for the oral disintegrating tablet formulation in amyotrophic lateral sclerosis (ALS) and Charcot-Marie-Tooth (CMT). Flex Pharma said